Rare diseases
Investigational molecules
Locations
852 Winter Street Suite 250, 02451-1439, United States
Zenas Biopharma (USA) LLC funds clinical research in IgG4-related disease, systemic lupus erythematosus, and warm autoimmune hemolytic anemia, with a clear focus on conditions driven by immune dysregulation and inflammatory activity.
Its research interests include disease control, flare prevention, anemia-related outcomes, and the management of immune-mediated tissue involvement.
Zenas Biopharma (USA) LLC runs clinical trials in conditions such as Primary progressive multiple sclerosis, Systemic lupus erythematosus, Relapsing-remitting multiple sclerosis, Immunoglobulin G4 related disease, among others.
Clinical trials run by this sponsor – those enrolling participants first.
AustriaOrelabrutinib in Patients with Primary Progressive Multiple Sclerosis
AustriaStudy of Obexelimab Treatment for Adults with Systemic Lupus Erythematosus (SLE)
BelgiumStudy on the Effects of Obexelimab for Patients with Relapsing Multiple Sclerosis
AustriaStudy on the Effects of Obexelimab for Patients with IgG4-Related Disease
FranceStudy of Obexelimab for Patients with Warm Autoimmune Hemolytic Anemia
ItalyIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
